| Application no. and date | 19189010.2 (espacenet) (Federated) (European Patent Register), 20171013 | | Patent/reg. no. and date | DK/EP 3640251, 20211208 | | Publication date | 20200422 | | Priority no. and date | US 201662411799 P, 20161024, US 201662435159 P, 20161216 | | EP pub. no. and date |
EP 3640251 20200422 | | Effective date | | | Applicant/owner | Astrazeneca AB, 151 85 Södertälje, SE | | Applicant ref. no. | 1595319 | | Inventor | YANG, Bin, AstraZeneca
35 Gatehouse Drive
Waltham, MA 02451, US,
SCOTT, James Stewart, AstraZeneca,
Darwin Building
Cambridge Science Park
Milton Road
Cambridge
Cambridgeshire CB4 0WG, GB,
BARLAAM, Bernard Christophe, AstraZeneca,
Darwin Building
Cambridge Science Park
Milton Road
Cambridge
Cambridgeshire CB4 0WG, GB,
MOSS, Thomas Andrew, AstraZeneca,
Darwin Building
Cambridge Science Park
Milton Road
Cambridge
Cambridgeshire CB4 0WG, GB,
HUGHES, Samantha Jayne, AstraZeneca,
Darwin Building
Cambridge Science Park
Milton Road
Cambridge
Cambridgeshire CB4 0WG, GB,
NISSINK, Johannes Wilhelmus Maria, AstraZeneca,
Darwin Building
Cambridge Science Park
Milton Road
Cambridge
Canbridgeshire CB4 0WG, GB,
O'DONOVAN, Daniel Hillebrand, AstraZeneca,
Darwin Building
Cambridge Science Park
Milton Road
Cambridge
Cambridgeshire CB4 0WG, GB | | Representative | RWS Group, RWS Compass House
Vanwall Business Park, Vanwall Road
Maidenhead, Berkshire
SL6 4UB, GB | | Opponent | | | IPC Class | A61K 31/4738 (2006.01) , A61K 31/497 (2006.01) , A61P 35/00 (2006.01) , C07D 471/04 (2006.01) | | Title | 6,7,8,9-TETRAHYDRO-3H-PYRAZOLO[4,3-F]ISOQUINOLINDERIVATER, SOM FINDER ANVENDELSE VED BEHANDLING AF CANCER | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
